Global Reye Syndrome Treatment Market, By Treatment (Intravenous Fluids, Corticosteroids, Diuretics, Antifibrinolytics, Surgery, Others), End-Users (Clinics, Hospitals, Research Laboratories, Ambulatory Surgical Centre, Others), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Reye syndrome treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 5.80% in the above-mentioned research forecast period. Increasing population of children worldwide and growing cases of influenza infections among children.
Advancement in diagnostic tools so as to accurately diagnose the disease symptoms and developing biotechnology and pharmaceutical sector also boost up the market growth. Moreover, increasing partnership and collaboration among market players and increasing per capita income act as opportunity for the market growth. But, lack of disease awareness, limited treatment options and strict regulations may hamper the global Reye syndrome treatment market.
Reye syndrome is characterized as one of the rare disorder that leads to brain and liver damage. It can affect at any stage of life to children. The children who have recently been passed through any viral infection are more prone to Reye syndrome moreover high intake of Aspirin also enhances the chances of Reye syndrome. Most commonly reported viral pathogens responsible to cause Reye syndrome includes influenza A and B along with varicella. As per the CDC Reye syndrome is defined as acute non- inflammatory encephalopathy marked by an alteration in consciousness, a record of cerebrospinal fluid having less than or equal to 8 leukocytes/cu.mm with meningeal inflammation. The children suffering from Reye syndrome have to pass through surgical procedure which includes placement of central venous access, airway intubation, Foley catheter. Moreover liver biopsy and intracranial pressure monitoring is also performed so as to maintain the health of children suffering from Reye syndrome. Aggressive treatment suggested for Reye syndrome includes administration of intravenous fluids, diuretics, corticosteroids so as to reduce inflammatory symptoms, medication in order to prevent bleeding among others.
The increasing case of viral infections among children is one of the major causes of Reye syndrome. As per the NCBI publication of 2020, this has been estimated that seasonal virus influenza is one of the major causes of respiratory infection in children. This has been concluded that in 2018, globally about 109. 5 million children under the age of 5 years suffered from acute lower respiratory infection caused by influenza virus. As the prevalence of viral infections is increasing at a rapid rate is expected to boost up the number of Reye syndrome patients and hence expected to provide market with the lucrative growth.
This Reye syndrome treatment market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Reye Syndrome Treatment Market Scope and Market Size
Reye syndrome treatment market is segmented on the basis of treatment, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of treatment, the Reye syndrome treatment market is segmented into intravenous fluids, corticosteroids, diuretics, antifibrinolytics, surgery, others. Intravenous segment is further sub-segmented into dextrose 5%, 0.9% normal saline, lactated ringers, others. Corticosteroids segment is further sub-segmented into dexamethasone and others. Antifibrinolytics is sub-segmented into tranexamic acid and others.
- On the basis of end-users, the Reye syndrome treatment market is segmented into clinics, hospitals, research laboratories, ambulatory surgical centre, others.
- On the basis of distribution channel, the Reye syndrome treatment market has also been segmented into retail pharmacy, hospital pharmacy, others.
Reye Syndrome Treatment Market Country Level Analysis
Reye syndrome treatment market is analysed and market size information is provided by country, treatment, end-users and distribution channel as referenced above.
The countries covered in the Reye syndrome treatment market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
On geographical estimation, North America accounts the largest market share due to the presence of a well-developed healthcare sector and rising healthcare expenditures. Moreover increasing children population susceptible to influenza infection is another factor driving the market growth. Europe accounts the second largest market share due to availability of funds for research activities related to rare diseases and presence of huge patient’s population. Asia-Pacific is expected to account for the largest market share over coming years for the Reye syndrome treatment market due to rising government support for children health and increasing investment for development of pharmaceutical and biotechnology industries.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Reye syndrome treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Reye Syndrome Treatment Market Share Analysis
Reye syndrome treatment market competitive landscape provides details by competitor, details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Reye syndrome treatment market.
The major players covered in the Reye syndrome treatment market are Pfizer Inc., Novartis AG, Merck KGaA, Sanofi SAIS, Baxter, Zydus Cadila, Par Pharmaceutical, Aspen Australia, Hikma, Cipla Inc., XSPIRE PHARMA, ACHÉ LABORATÓRIOS FARMACÊUTICOS S.A., Lupin Pharmaceuticals, Inc., Salius Pharma Private Limited, Soxa Formulations & Research(Pvt.) Ltd, Ami Lifesciences, Hangzhou Longshine Bio-Tech Co.,LTD., Schwitz Biotech, B. Braun Medical Inc., Fresenius Kabi India Pvt. Ltd., Beximco Pharmaceuticals Ltd. among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.